AXA's Hargraves and Grandsard to run Health and Biotech funds on interim basis

clock

AXA Investment Managers is to hand its Health and Biotech funds to Mark Hargraves and Bruno Grandsard on a temporary basis.

The group confirmed Gemma Game - who is replacing exiting manager Deane Donnigan as lead on the funds when she departs in June - is stepping down temporarily to take maternity leave. Hargraves, head of continental Europe, runs AXA's European fund, while Grandsard is a portfolio manager within the global equities team. The duo will take charge over the summer. The company said in a statement: "During a short period while Gemma is on maternity leave over the summer, the portfolios will be run by members of the existing global equity team Mark Hargraves and Bruno Grandsard. "We are co...

To continue reading this article...

Join Investment Week for free

  • Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
  • Get ahead of regulatory and technological changes affecting fund management
  • Important and breaking news stories selected by the editors delivered straight to your inbox each day
  • Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
  • Be the first to hear about our extensive events schedule and awards programmes

Join now

 

Already an Investment Week
member?

Login

More on Economics

Trustpilot